The total pharmaceutical sales in Finland have shown steady growth over the past years. In 2023, the sales stood at €3.10 billion. The forecasted data from 2024 to 2028 shows a consistent year-on-year increase, with percentages varying between 3% to 4%. The Compound Annual Growth Rate (CAGR) over the next five years is approximately 2.7%, reflecting a stable upward trend in the pharmaceutical market.
Future trends to watch for include:
• Increased adoption of digital health technologies and telemedicine.
• Development and integration of personalized medicine and biotechnology.
• Policy changes affecting drug pricing and reimbursement.
• Growing focus on chronic disease management and preventive care.
